证券记录 · 已归档季度
INSM
Insmed Incorporated · Healthcare · Biotechnology
18被追踪持有人
+1Δ持有人
70.35M持有股份
$7.08B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +5.9% ·
股份流向 +3.7% ·
净新建仓位 +5.6%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.33M | $149.97M | n/a | −2 |
| Q2 2026 | 156 | -6 | 147.06M | $15.68B | +6 | −13 |
| Q1 2026 | 166 | +6 | 152.11M | $24.63B | +9 | −4 |
| Q4 2025 | 159 | -1 | 156.45M | $27.23B | +1 | −1 |
| Q3 2025 | 21 | +1 | 121.03M | $17.43B | +1 | −1 |
| Q2 2025 | 18 | +1 | 70.35M | $7.08B | +2 | −1 |
| Q1 2025 | 14 | -1 | 33.99M | $2.59B | n/a | −1 |
| Q4 2024 | 15 | 0 | 31.46M | $2.17B | +1 | −1 |
| Q3 2024 | 14 | -1 | 23.46M | $1.71B | n/a | −1 |
| Q2 2024 | 15 | n/a | 25.91M | $1.74B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 17.64M | n/a | $1.78B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | T. Rowe Price ✦ | 11.23M | -13.1% | $1.13B | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (被动) | 11.14M | n/a | $1.12B | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 4 | Fidelity (FMR) ✦ | 5.09M | n/a | $512.59M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 5 | State Street Global Advisors ✦ (被动) | 4.28M | -25.6% | $430.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 3.42M | +365.7% | $344.45M | 0.4% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (被动) | 3.34M | -22.1% | $336.26M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 2.86M | -17.0% | $287.78M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 9 | Duquesne Family Office ✦ | 2.25M | +64.6% | $226.79M | 5.8% | ▲ Add | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 2.12M | +212.4% | $213.53M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 1.93M | +11.0% | $194.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.53M | +309.1% | $154.31M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | Wellington Management ✦ | 1.16M | -5.2% | $116.71M | 0.0% | ▼ Trim | 5 | SEC ↗ ×7 |
| 14 | Marshall Wace ✦ | 1.11M | +59.9% | $112.05M | 0.1% | ▲ Add | 5 | SEC ↗ ×3 |
| 15 | Point72 Asset Management ✦ | 490.67K | 新增 | $49.38M | 0.1% | New | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 376.51K | -7.5% | $37.89M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 308.69K | 新增 | $31.07M | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 49.72K | -3.0% | $5.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $49.38M | 0.1% |
| Renaissance Technologies | $31.07M | 0.0% |
已清仓
| Soros Fund Management | $23.44M | 曾为 0.6% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 664 持有人, 192.22M 股份, $30.07B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 09
Brennan David R
Director · 25.00K 股 · $3.10M
Aug 17
SHAROKY MELVIN MD
Director · 5.00K 股 · $637,650
Aug 10
Adsett Roger
Officer · 239.85K 股 · $31.96M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: Darwin Global Management, Ltd.
Aug 06
SC 13G/A: FMR LLC
Jul 22
SC 13G/A: JPMORGAN CHASE & CO
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据